Nails in chemotherapy: dry, unsealed, and agreed with oncology first

A stethoscope in front of a laptop is the right order for nail care during chemotherapy, and the order matters more than the products on the trolley. The decision is not made in the cabin alone. It is made in agreement with the oncology lead, by name, in the current cycle. Cytostatic drugs hit matrix and plate, and they hit them in patterns you can learn without pretending to manage the drug. Taxanes, docetaxel and paclitaxel, travel with onycholysis, Beau’s lines and subungual bleeding. EGFR inhibitors produce painful paronychia, sometimes with exuberant granulation at the wall. Capecitabine and other agents discolour, thin and ridge the plate. None of these pictures is a cosmetic project. Clumsy care can make every one of them worse, and worse here means a wound in a person whose white cells may already be low.

If the appointment is accepted at all, the brief is conservative to the point of looking like very little. Work dry. Set no trauma. Seal nothing that hides a change the oncology team needs to see at the next review. The client sits inside a system of blood counts, infection defence and a treatment plan that does not pause because a cabin had a gap on Thursday. A clinic that does not know that plan should leave the nail alone. At industry practice the language around oncology-safe overlays is already on the product lines, in calm type. The safe version is usually the one that stays off the plate. Safe, in this aisle, is often a synonym for absent.

What the drugs write, and when the writing shows

The matrix builds the plate. A disturbance there appears weeks later as a Beau’s line, a groove that travels forward with growth, or as a thin, brittle plate that splits on a handbag. Onycholysis under taxanes lifts the plate off the bed and leaves a cleft. That cleft is kept dry. Moisture, gel, acrylic or a glued tip turns the cleft into a reservoir, which is a word from microbiology and the correct word. Subungual haematomas are painful. They are a poor field for a burr, however steady the hand and however much the client wants the dark patch gone before a family lunch.

Under EGFR inhibitors the main problem is often the wall, and the wall can look like a problem podiatry already knows. Skin at the nail edge inflames, fissures, and builds excess tissue. It can look like an ingrown nail. It is an adverse effect of the drug, and cutting into it as if it were a mechanical ingrown is how a cabin manufactures bleeding. Seating a brace on a cosmetic impulse, or applying high-percentage urea, can bleed and infect, particularly when neutrophils are low. Oncology clinics know these pictures. The cabin should recognise them and hand them back, with the drug name attached, rather than with a new shape filed into the wall.

The patterns differ by class, which is why an appointment card that says chemo and omits the agent is not a history. Anthracyclines, taxanes, EGFR blockers and capecitabine write different marks into matrix, bed and wall. The clinic does not dose the drug and does not comment on the dose. It needs to be able to name the agent before an instrument touches the plate. Naming is the minimum competence. Everything else is manicure habits imported into the wrong month.

Timing weighs as much as the substance, and timing is the detail clients feel least like discussing because they feel, that morning, surprisingly well. In the nadir, when white cells sit at their lowest after a cycle, every small wound is an infection risk. Many oncology teams want no nail procedure in that window, including the ones labelled cosmetic, because cosmetic is a poor disinfectant. That instruction lives in the letter, or it is asked. It is not inferred from how steady the client seems in the chair. A person can feel steady and still be neutropenic. The feeling is real. The count is the document.

Barrier work, with reconstruction left in the other room

What remains is small, and it has to be clean, which is a higher standard than a new coat of something fragrant. The plate is not thinned. No burr takes keratin off so the surface looks smoother in a photograph the client will not need. No cut runs into the sulcus. Length is reduced only far enough that a brittle free edge will not tear, with a disinfected sharp nipper, in one cut, without ripping. Inflamed skin at the wall is left uncut, even when it looks like the thing you know how to tidy. A thin, fragrance-free lipid film on intact surrounding skin lowers friction. That is a barrier. Onycholysis remains a finding of the drug. The film does not treat it, and should not be introduced as if it did.

Urea at a low concentration can make dry, still-closed skin more pliable, a modest help with a modest claim. High-percentage keratolytic ointments on a toxically damaged plate are out of place, however much the dryness seems to ask for them. Essential oils, antifungal drops without a diagnosis, UV gels used as camouflage, acetone baths: strike them from the visit. Clients often want exactly that gel, because the nail bothers them in daily life and the illness is already visible enough without a bare, ridged plate. The honest answer is that a seal removes the view the oncology team needs of this particular nail. A breathable protective film, if the physician clears it in writing, is a different object from a salon gel. The clearance is the difference. The word breathable is not.

Sterile working here is behaviour, not a coat for a photograph. No reused file. No wounds made. Hands, surfaces and instruments handled as they would be for work close to broken skin, because the skin may become broken if you are careless by a millimetre. When the doubt is real, the appointment gets shorter. Sometimes it does not happen. Both outcomes are competent. Heroism at the matrix is the incompetent one.

During chemotherapy the nail is a finding of the treatment. Reconstruction is a different brief, and this is not its month.

Agreement, the window, and the stop

Without a clear yes from the treating side, the visit stays with advice and with skin care of the hands, away from the nail unit, which can feel like a refusal and is in fact the treatment.

• Clarify beforehand: agent, point in the cycle, the latest blood-count note, and whether the practice clears nail care in the current window. Put the contact name on the card, where a colleague can find it.
• No gel, no acrylic, no tips, no seal over onycholysis or over a discolouration that has not been explained. Hide nothing a physician needs to see, including the change the client finds ugly.
• No burr, no cut into the wall, no evacuation of haematomas. Secure length only when the plate can take the mechanical load of a single clean cut.
• Fragrance-free, simple lipids on intact skin. High-percentage keratolytics, essential-oil blends and a homemade repair course stay out of the bag you send her home with.
• Stop for redness, pus, blackening, acute pain, fever, or when the client cannot name the point in the cycle. The next appointment is then in oncology, and the cabin’s job is the sentence that gets her there.

Photographs, same light, go to the patient for her treatment team. Documentation here is a handover. It is a poor feed, and it should look like a handover: dated, plain, unfiltered. Stands at industry practice that sell camouflage systems for chemo nails should be asked who on the oncology side has cleared the seal. If the answer is the brochure, the brochure is the whole of the evidence, and the evidence is thin.

What a good visit looks like when nothing dramatic happened

Success is a client who leaves the cycle without a new wound at the nail. A longer plate, a shine, a before-and-after: none of that is the endpoint, and chasing it is how wounds get made by people who meant to help. Beau’s lines will come if the matrix was hit. They grow out over months, on the nail’s own clock, which does not consult the calendar of events she hoped to attend with a tidy hand. Onycholysis under taxanes follows the drug and the dose. A care film does not outvote either, however careful the film and however kind the room.

The hierarchy in the photograph holds, and it should be felt in the appointment as a relief rather than as a demotion. Oncology leads. The clinic supports conservatively, with dry work and a short visit, or it keeps its hands off. Both are competent. A heroic intervention at the matrix is a story for a different patient, in a different month, with counts this chair does not hold.